- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Spine Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Spine Biologics market size is estimated to be worth US$ 2431.4 million in 2021 and is forecast to a readjusted size of USD 3022.6 million by 2028 with a CAGR of 3.2% during review period. Anterior Cervical Discectomy and Fusion accounting for % of the Spine Biologics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bone Graft segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Spine Biologics include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, and Zimmer Biomet, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Spine Biologics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)
Market segment by Application can be divided into
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Others
The key market players for global Spine Biologics market are listed below:
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spine Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Spine Biologics, with price, sales, revenue and global market share of Spine Biologics from 2019 to 2022.
Chapter 3, the Spine Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spine Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Spine Biologics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Spine Biologics.
Chapter 13, 14, and 15, to describe Spine Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Spine Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Spine Biologics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Bone Graft
1.2.3 Bone Graft Substitute
1.2.4 Platelet Rich Plasma (PRP)
1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
1.3 Market Analysis by Application
1.3.1 Overview: Global Spine Biologics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.3.4 Others
1.4 Global Spine Biologics Market Size & Forecast
1.4.1 Global Spine Biologics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Spine Biologics Sales in Volume (2017-2028)
1.4.3 Global Spine Biologics Price (2017-2028)
1.5 Global Spine Biologics Production Capacity Analysis
1.5.1 Global Spine Biologics Total Production Capacity (2017-2028)
1.5.2 Global Spine Biologics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Spine Biologics Market Drivers
1.6.2 Spine Biologics Market Restraints
1.6.3 Spine Biologics Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Spine Biologics Product and Services
2.1.4 Medtronic Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Depuy Synthes
2.2.1 Depuy Synthes Details
2.2.2 Depuy Synthes Major Business
2.2.3 Depuy Synthes Spine Biologics Product and Services
2.2.4 Depuy Synthes Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Spine Biologics Product and Services
2.3.4 Stryker Corporation Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nuvasive
2.4.1 Nuvasive Details
2.4.2 Nuvasive Major Business
2.4.3 Nuvasive Spine Biologics Product and Services
2.4.4 Nuvasive Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zimmer Biomet
2.5.1 Zimmer Biomet Details
2.5.2 Zimmer Biomet Major Business
2.5.3 Zimmer Biomet Spine Biologics Product and Services
2.5.4 Zimmer Biomet Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Orthofix International
2.6.1 Orthofix International Details
2.6.2 Orthofix International Major Business
2.6.3 Orthofix International Spine Biologics Product and Services
2.6.4 Orthofix International Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spine Biologics Product and Services
2.7.4 Globus Medical Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 alphatec spine
2.8.1 alphatec spine Details
2.8.2 alphatec spine Major Business
2.8.3 alphatec spine Spine Biologics Product and Services
2.8.4 alphatec spine Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 K2M
2.9.1 K2M Details
2.9.2 K2M Major Business
2.9.3 K2M Spine Biologics Product and Services
2.9.4 K2M Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Exactech
2.10.1 Exactech Details
2.10.2 Exactech Major Business
2.10.3 Exactech Spine Biologics Product and Services
2.10.4 Exactech Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Wright Medical Technology
2.11.1 Wright Medical Technology Details
2.11.2 Wright Medical Technology Major Business
2.11.3 Wright Medical Technology Spine Biologics Product and Services
2.11.4 Wright Medical Technology Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 X-Spine
2.12.1 X-Spine Details
2.12.2 X-Spine Major Business
2.12.3 X-Spine Spine Biologics Product and Services
2.12.4 X-Spine Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Nutech
2.13.1 Nutech Details
2.13.2 Nutech Major Business
2.13.3 Nutech Spine Biologics Product and Services
2.13.4 Nutech Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Arthrex
2.14.1 Arthrex Details
2.14.2 Arthrex Major Business
2.14.3 Arthrex Spine Biologics Product and Services
2.14.4 Arthrex Spine Biologics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Spine Biologics Breakdown Data by Manufacturer
3.1 Global Spine Biologics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Spine Biologics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Spine Biologics
3.4 Market Concentration Rate
3.4.1 Top 3 Spine Biologics Manufacturer Market Share in 2021
3.4.2 Top 6 Spine Biologics Manufacturer Market Share in 2021
3.5 Global Spine Biologics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Spine Biologics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Spine Biologics Market Size by Region
4.1.1 Global Spine Biologics Sales in Volume by Region (2017-2028)
4.1.2 Global Spine Biologics Revenue by Region (2017-2028)
4.2 North America Spine Biologics Revenue (2017-2028)
4.3 Europe Spine Biologics Revenue (2017-2028)
4.4 Asia-Pacific Spine Biologics Revenue (2017-2028)
4.5 South America Spine Biologics Revenue (2017-2028)
4.6 Middle East and Africa Spine Biologics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Spine Biologics Sales in Volume by Type (2017-2028)
5.2 Global Spine Biologics Revenue by Type (2017-2028)
5.3 Global Spine Biologics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Spine Biologics Sales in Volume by Application (2017-2028)
6.2 Global Spine Biologics Revenue by Application (2017-2028)
6.3 Global Spine Biologics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Spine Biologics Sales by Type (2017-2028)
7.2 North America Spine Biologics Sales by Application (2017-2028)
7.3 North America Spine Biologics Market Size by Country
7.3.1 North America Spine Biologics Sales in Volume by Country (2017-2028)
7.3.2 North America Spine Biologics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Spine Biologics Sales by Type (2017-2028)
8.2 Europe Spine Biologics Sales by Application (2017-2028)
8.3 Europe Spine Biologics Market Size by Country
8.3.1 Europe Spine Biologics Sales in Volume by Country (2017-2028)
8.3.2 Europe Spine Biologics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Spine Biologics Sales by Type (2017-2028)
9.2 Asia-Pacific Spine Biologics Sales by Application (2017-2028)
9.3 Asia-Pacific Spine Biologics Market Size by Region
9.3.1 Asia-Pacific Spine Biologics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Spine Biologics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Spine Biologics Sales by Type (2017-2028)
10.2 South America Spine Biologics Sales by Application (2017-2028)
10.3 South America Spine Biologics Market Size by Country
10.3.1 South America Spine Biologics Sales in Volume by Country (2017-2028)
10.3.2 South America Spine Biologics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Spine Biologics Sales by Type (2017-2028)
11.2 Middle East & Africa Spine Biologics Sales by Application (2017-2028)
11.3 Middle East & Africa Spine Biologics Market Size by Country
11.3.1 Middle East & Africa Spine Biologics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Spine Biologics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Spine Biologics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Spine Biologics
12.3 Spine Biologics Production Process
12.4 Spine Biologics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Spine Biologics Typical Distributors
13.3 Spine Biologics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Spine Biologics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Spine Biologics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Spine Biologics Product and Services
Table 6. Medtronic Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Depuy Synthes Basic Information, Manufacturing Base and Competitors
Table 8. Depuy Synthes Major Business
Table 9. Depuy Synthes Spine Biologics Product and Services
Table 10. Depuy Synthes Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Stryker Corporation Major Business
Table 13. Stryker Corporation Spine Biologics Product and Services
Table 14. Stryker Corporation Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nuvasive Basic Information, Manufacturing Base and Competitors
Table 16. Nuvasive Major Business
Table 17. Nuvasive Spine Biologics Product and Services
Table 18. Nuvasive Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 20. Zimmer Biomet Major Business
Table 21. Zimmer Biomet Spine Biologics Product and Services
Table 22. Zimmer Biomet Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Orthofix International Basic Information, Manufacturing Base and Competitors
Table 24. Orthofix International Major Business
Table 25. Orthofix International Spine Biologics Product and Services
Table 26. Orthofix International Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 28. Globus Medical Major Business
Table 29. Globus Medical Spine Biologics Product and Services
Table 30. Globus Medical Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. alphatec spine Basic Information, Manufacturing Base and Competitors
Table 32. alphatec spine Major Business
Table 33. alphatec spine Spine Biologics Product and Services
Table 34. alphatec spine Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. K2M Basic Information, Manufacturing Base and Competitors
Table 36. K2M Major Business
Table 37. K2M Spine Biologics Product and Services
Table 38. K2M Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Exactech Basic Information, Manufacturing Base and Competitors
Table 40. Exactech Major Business
Table 41. Exactech Spine Biologics Product and Services
Table 42. Exactech Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Wright Medical Technology Basic Information, Manufacturing Base and Competitors
Table 44. Wright Medical Technology Major Business
Table 45. Wright Medical Technology Spine Biologics Product and Services
Table 46. Wright Medical Technology Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. X-Spine Basic Information, Manufacturing Base and Competitors
Table 48. X-Spine Major Business
Table 49. X-Spine Spine Biologics Product and Services
Table 50. X-Spine Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Nutech Basic Information, Manufacturing Base and Competitors
Table 52. Nutech Major Business
Table 53. Nutech Spine Biologics Product and Services
Table 54. Nutech Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Arthrex Basic Information, Manufacturing Base and Competitors
Table 56. Arthrex Major Business
Table 57. Arthrex Spine Biologics Product and Services
Table 58. Arthrex Spine Biologics Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Spine Biologics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Spine Biologics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Spine Biologics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Spine Biologics Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Spine Biologics Production Site of Key Manufacturer
Table 64. Spine Biologics New Entrant and Capacity Expansion Plans
Table 65. Spine Biologics Mergers & Acquisitions in the Past Five Years
Table 66. Global Spine Biologics Sales by Region (2017-2022) & (K Units)
Table 67. Global Spine Biologics Sales by Region (2023-2028) & (K Units)
Table 68. Global Spine Biologics Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Spine Biologics Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 71. Global Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 72. Global Spine Biologics Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Spine Biologics Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Spine Biologics Price by Type (2017-2022) & (USD/Unit)
Table 75. Global Spine Biologics Price by Type (2023-2028) & (USD/Unit)
Table 76. Global Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 77. Global Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 78. Global Spine Biologics Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Spine Biologics Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Spine Biologics Price by Application (2017-2022) & (USD/Unit)
Table 81. Global Spine Biologics Price by Application (2023-2028) & (USD/Unit)
Table 82. North America Spine Biologics Sales by Country (2017-2022) & (K Units)
Table 83. North America Spine Biologics Sales by Country (2023-2028) & (K Units)
Table 84. North America Spine Biologics Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Spine Biologics Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 87. North America Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 88. North America Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 89. North America Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 90. Europe Spine Biologics Sales by Country (2017-2022) & (K Units)
Table 91. Europe Spine Biologics Sales by Country (2023-2028) & (K Units)
Table 92. Europe Spine Biologics Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Spine Biologics Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 95. Europe Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 96. Europe Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 97. Europe Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Spine Biologics Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Spine Biologics Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Spine Biologics Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Spine Biologics Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 106. South America Spine Biologics Sales by Country (2017-2022) & (K Units)
Table 107. South America Spine Biologics Sales by Country (2023-2028) & (K Units)
Table 108. South America Spine Biologics Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Spine Biologics Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 111. South America Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 112. South America Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 113. South America Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Spine Biologics Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Spine Biologics Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Spine Biologics Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Spine Biologics Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Spine Biologics Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Spine Biologics Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Spine Biologics Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Spine Biologics Sales by Application (2023-2028) & (K Units)
Table 122. Spine Biologics Raw Material
Table 123. Key Manufacturers of Spine Biologics Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Spine Biologics Typical Distributors
Table 127. Spine Biologics Typical Customers
List of Figures
Figure 1. Spine Biologics Picture
Figure 2. Global Spine Biologics Revenue Market Share by Type in 2021
Figure 3. Bone Graft
Figure 4. Bone Graft Substitute
Figure 5. Platelet Rich Plasma (PRP)
Figure 6. BMAC (Bone Marrow Aspirate Concentrate)
Figure 7. Global Spine Biologics Revenue Market Share by Application in 2021
Figure 8. Anterior Cervical Discectomy and Fusion
Figure 9. Posterior Lumbar Interbody Fusion
Figure 10. Others
Figure 11. Global Spine Biologics Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Spine Biologics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Spine Biologics Sales (2017-2028) & (K Units)
Figure 14. Global Spine Biologics Price (2017-2028) & (USD/Unit)
Figure 15. Global Spine Biologics Production Capacity (2017-2028) & (K Units)
Figure 16. Global Spine Biologics Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Spine Biologics Market Drivers
Figure 18. Spine Biologics Market Restraints
Figure 19. Spine Biologics Market Trends
Figure 20. Global Spine Biologics Sales Market Share by Manufacturer in 2021
Figure 21. Global Spine Biologics Revenue Market Share by Manufacturer in 2021
Figure 22. Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Spine Biologics Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Spine Biologics Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Spine Biologics Sales Market Share by Region (2017-2028)
Figure 26. Global Spine Biologics Revenue Market Share by Region (2017-2028)
Figure 27. North America Spine Biologics Revenue (2017-2028) & (USD Million)
Figure 28. Europe Spine Biologics Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Spine Biologics Revenue (2017-2028) & (USD Million)
Figure 30. South America Spine Biologics Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Spine Biologics Revenue (2017-2028) & (USD Million)
Figure 32. Global Spine Biologics Sales Market Share by Type (2017-2028)
Figure 33. Global Spine Biologics Revenue Market Share by Type (2017-2028)
Figure 34. Global Spine Biologics Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Spine Biologics Sales Market Share by Application (2017-2028)
Figure 36. Global Spine Biologics Revenue Market Share by Application (2017-2028)
Figure 37. Global Spine Biologics Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Spine Biologics Sales Market Share by Type (2017-2028)
Figure 39. North America Spine Biologics Sales Market Share by Application (2017-2028)
Figure 40. North America Spine Biologics Sales Market Share by Country (2017-2028)
Figure 41. North America Spine Biologics Revenue Market Share by Country (2017-2028)
Figure 42. United States Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Spine Biologics Sales Market Share by Type (2017-2028)
Figure 46. Europe Spine Biologics Sales Market Share by Application (2017-2028)
Figure 47. Europe Spine Biologics Sales Market Share by Country (2017-2028)
Figure 48. Europe Spine Biologics Revenue Market Share by Country (2017-2028)
Figure 49. Germany Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Spine Biologics Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Spine Biologics Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Spine Biologics Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Spine Biologics Revenue Market Share by Region (2017-2028)
Figure 58. China Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Spine Biologics Sales Market Share by Type (2017-2028)
Figure 65. South America Spine Biologics Sales Market Share by Application (2017-2028)
Figure 66. South America Spine Biologics Sales Market Share by Country (2017-2028)
Figure 67. South America Spine Biologics Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Spine Biologics Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Spine Biologics Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Spine Biologics Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Spine Biologics Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Spine Biologics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Spine Biologics in 2021
Figure 79. Manufacturing Process Analysis of Spine Biologics
Figure 80. Spine Biologics Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
